Chemistry: analytical and immunological testing – Clotting or clotting factor level tests
Patent
1995-08-17
1998-01-06
Wallenhorst, Maureen M.
Chemistry: analytical and immunological testing
Clotting or clotting factor level tests
436 18, 436175, 435 13, 536 21, G01N 3386
Patent
active
057053960
ABSTRACT:
The accuracy of a diagnostic test for determining the coagulability of blood is improved by reducing the interference by heparin. At least one metal salt, preferably a copper or zinc salt, is added to the diagnostic test to avoid or considerably reduce the undesirable influence of heparin on the test.
REFERENCES:
patent: 4199502 (1980-04-01), Babson et al.
patent: 4226599 (1980-10-01), Butler et al.
patent: 4250041 (1981-02-01), Babson et al.
patent: 5000854 (1991-03-01), Yang
patent: 5039529 (1991-08-01), Bergendal et al.
patent: 5151192 (1992-09-01), Matkovich et al.
patent: 5286388 (1994-02-01), Ingram
patent: 5451509 (1995-09-01), Speck
Gervin et al. Clinical Research, vol. 28(1), 1980, p. 90A.
Liu et al. Thrombosis & Haemostasis, vol. 66 (6), 1991, p. 742.
Liu et al. Carbohydrate Research, vol. 255, Mar. 4, 1994, pp. 183-191.
Stivala Federation Proceedings, vol. 36, No. 1, Jan. 1977, pp. 83-88.
Greenberg et al. American Journal of Clinical Pathology, vol. 86 (4), 1986, pp. 484-489.
Cumming et al., "In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: an assessment of four heparin antagonists and two anion exchange resins," Chemical Abstracts, vol. 104, No. 15 (Apr. 14, 1986), p. 340.
Kazama et al., "Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein," Chemical Abstracts, vol. 116, No. 19 (May 11, 1992), p. 42.
Koide et al., "Effects of zinc and calcium ions on the neutralization by histidine-rich glycoprotein of the heparin-dependent activities of plasma proteinase inhibitors," Chemical Abstracts, vol. 115, No. 1 (Jul. 8, 1991), p. 5752.
Stivala et al., "Physicochemical studies of fractionated bovine heparin. IV. Copper(II) binding in relation to pH molecular weight and biological activity," Chemical Abstracts, vol. 67, No. 23 (Dec. 4, 1967), p. 115408.
Godal, H.C., "A Comparison Of Two Heparin-Neutralizing Agents: Protamine And Polybrene," Scandinav. J. Clin. & Lab. Investigation, vol. 12, pp. 446-457 (1960).
Grant et al., "Zn.sup.2+ heparin interaction studied by potentiometric titration," Biochem J., vol. 287, pp. 849-853 (1992).
Grant et al., "Complexation of Zn.sup.2+ ions by heparin," Biochemical Society Transactions, vol. 20, p. 363S (1992).
Jorpes et al., "Neutralisation Of Action Of Heparin By Protamine," The Lancet, vol. 2, pp. 975-976 (1939).
Lages et al., "Interaction of the Polyelectrolyte Heparin with Copper(II) and Calcium," Biopolymers, vol. 12, pp. 127-143 (1973).
Lindahl et al., "Glycosaminoglycans And Their Binding To Biological Macro-molecules," Ann. Rev. Biochem., vol. 47, pp. 385-417 (1978).
Mattai et al., "Quantitative similarity of zinc and calcium binding to heparin in excess salt solution," Biophysical Chemistry, vol. 31, pp. 295-299 (1988).
Parrish et al., "Selective binding of zinc ions to heparin rather than to other glycosaminoglycans," Biochem J., vol. 193, pp. 407-410 (1981).
Pedersen et al., "Inhibition of Recombinant Human Blood Coagulation Factor VIIa Amidolytic and Proteolytic Activity by Zinc Ions," Thrombosis and Haemostasis, vol. 65(5), pp. 528-534 (1991).
Speight et al., "Calcium Inhibits the Heparin-Catalyzed Antithrombin III/Thrombin Reaction by Decreasing the Apparent Binding Affinity of Heparin for Thrombin," Archives of Biochemistry and Biophysics, vol. 225, No. 2, pp. 958-963 (1983).
van den Besselaar et al., "Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing," Blood Coagulation and Fibrinolysis, vol. 4, pp. 635-638 (1993).
Whitfield et al., "Heavy Metal Binding to Heparin Disaccharides. II. First Evidence for Zinc Chelation," Biopolymers, vol. 32, pp. 597-619 (1992).
Fickenscher Karl
Zander Norbert
Behringwerke Diagnostics GmbH
Wallenhorst Maureen M.
LandOfFree
Additive for diagnostic tests for determination of the coagulabi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Additive for diagnostic tests for determination of the coagulabi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Additive for diagnostic tests for determination of the coagulabi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2328483